A detailed history of Rothschild Investment LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 540 shares of REGN stock, worth $447,346. This represents 0.04% of its overall portfolio holdings.

Number of Shares
540
Previous 596 9.4%
Holding current value
$447,346
Previous $626 Million 9.38%
% of portfolio
0.04%
Previous 0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$1024.09 - $1201.76 $57,349 - $67,298
-56 Reduced 9.4%
540 $568 Million
Q2 2024

Jul 30, 2024

BUY
$883.2 - $1071.19 $526,387 - $638,429
596 New
596 $626 Million
Q1 2024

Jul 31, 2024

BUY
$902.69 - $993.35 $10,832 - $11,920
12 Added 2.4%
513 $494 Million
Q4 2023

Jul 31, 2024

SELL
$775.18 - $881.7 $73,642 - $83,761
-95 Reduced 15.94%
501 $440 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $88.8B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Rothschild Investment LLC Portfolio

Follow Rothschild Investment LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment LLC with notifications on news.